<DOC>
	<DOCNO>NCT02162199</DOCNO>
	<brief_summary>The sponsor try develop medicine infection cure regular antibiotic . They experimental drug call Debio 1450 may work . They need 48 healthy adult volunteer study . This study look body drug . It measure amount drug blood urine change time . From screen visit follow-up visit may 40 day . Volunteers go clinic Baltimore screening visit . The study doctor choose qualified volunteer participate serve alternate . Alternates might actually complete study procedure . The study doctor divide participant group eight . Six receive Debio 1450 2 receive Placebo . The drug participant receive decide chance - like flip coin . Eligible volunteer check clinic test chosen participate remain 5-day/ 4-night stay . The clinic serf standard meal , except fast require . Participants must stay clinic length study . This study `` dose escalation '' study . That mean safety concern come new group start . Each new group eight participant receive capsule . The study product contain capsule . Each capsule contain either placebo 40 mg Debio 1450 . After fast overnight , first two participant group receive capsule . One get Debio 1450 one get Placebo . If participant tolerate side effect 24 hour , remain six participant receive assign capsule . The plan increase dose next group . The study doctor review measurement collect group three day . He may decide repeat , increase , low dose even stop study . The participant receive 800 mg 20 capsule .</brief_summary>
	<brief_title>A Single Dose Study Debio 1450 Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<criteria>1 . Is healthy adult 2 . Has meet protocolspecified criterion qualification use contraception 3 . Is willing able remain confine study unit entire duration treatment period comply restriction relate food , drink medication 4 . Has voluntarily consent participate provide write informed consent prior protocolspecific procedure 1 . Has screen laboratory value outside protocolspecified limit 2 . Has history clinically significant allergic drug reaction 3 . Has donate volume plasma whole blood within time frame allow per protocol 4 . Has historical current use allow per protocol : 1. overthecounter medication 2. certain food ; dietary , mineral herbal supplement 3. licit illicit drug ( include experimental drug , caffeine , nicotine alcohol ) 5 . Has sign , symptom history condition , per protocol opinion investigator , might compromise : 1. safety wellbeing participant study staff 2. safety wellbeing participant 's offspring ( pregnancy breastfeed ) 3. analysis result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Antibiotic</keyword>
	<keyword>Antibiotic Resistant Bacterial Infection</keyword>
</DOC>